 Connection
Kavita Nair to Retrospective Studies
This is a "connection" page, showing publications Kavita Nair has written about Retrospective Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.347 |
|
|
|
-
de Havenon A, Delic A, Dehoney S, Whetman P, Sheibani N, Callaghan B, Ney J, Esper GJ, Magliocco B, Nair KV. Five-Year Trends in Payments for Neurologist-Prescribed Drugs in Medicare Part D. Neurology. 2021 04 20; 96(16):e2132-e2137.
Score: 0.053
-
Page RL, Ghushchyan V, Van Den Bos J, Gray TJ, Hoetzer GL, Bhandary D, Nair KV. The cost of inpatient death associated with acute coronary syndrome. Vasc Health Risk Manag. 2016; 12:13-21.
Score: 0.037
-
Saseen JJ, Ghushchyan V, Nair KV. Comparing clinical effectiveness and drug toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in a managed care population. J Clin Hypertens (Greenwich). 2015 Feb; 17(2):134-40.
Score: 0.034
-
Saseen JJ, Ghushchyan V, Kaila S, Allen RR, Nair KV. Maintaining goal blood pressures after switching from olmesartan to other angiotensin receptor blockers. J Clin Hypertens (Greenwich). 2013 Dec; 15(12):888-92.
Score: 0.032
-
Nair KV, Naim AB, Draaghtel K, Van Den Bos J. Work absences and expenditures for employees with autoimmune inflammatory diseases. J Occup Environ Med. 2012 Oct; 54(10):1268-74.
Score: 0.030
-
Saseen JJ, Agashivala N, Allen RR, Ghushchyan V, Yadao AM, Nair KV. Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks. Rheumatology (Oxford). 2012 Nov; 51(11):2004-12.
Score: 0.029
-
Alford JC, Saseen JJ, Allen RR, Nair KV. Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions. Pharmacotherapy. 2012 Jul; 32(7):623-30.
Score: 0.029
-
Nair KV, Tang B, Van Den Bos J, Zhang V, Saseen JJ, Naim A, Rahman M. Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations. Curr Med Res Opin. 2009 Feb; 25(2):303-14.
Score: 0.023
-
Carlson AM, Sollero CEV, Wolf AB, Sillau S, Schmitt BL, Money KM, Nair KV, Piquet AL, Bennett JL. The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population. Ann Clin Transl Neurol. 2025 Jan; 12(1):169-179.
Score: 0.017
-
Crane PD, Sillau S, Dreher R, Fix R, Winters P, Van Coevering R, Engebretson E, Valdez B, Matthews E, Nair KV, Carlson AM, Piquet AL. Population-Based Study of the Epidemiology of Stiff Person Syndrome in a Large Colorado-Based Health System. Neurology. 2024 Dec 24; 103(12):e210078.
Score: 0.017
-
Wilson AM, Lundgren KB, Schierman B, Mante A, Lien A, Benish SM, Esper GJ, Nair KV, Ney JP. Examining the National Representativeness of the Axon Registry: A Neurology-Specific Patient Registry. Neurology. 2023 09 12; 101(11):e1167-e1177.
Score: 0.016
-
McQueen RB, Farahbakhshian S, Bell KF, Nair KV, Saseen JJ. Economic burden of comorbid chronic kidney disease and diabetes. J Med Econ. 2017 Jun; 20(6):585-591.
Score: 0.010
-
Dilokthornsakul P, Valuck RJ, Nair KV, Corboy JR, Allen RR, Campbell JD. Multiple sclerosis prevalence in the United States commercially insured population. Neurology. 2016 Mar 15; 86(11):1014-21.
Score: 0.009
-
Libby AM, Fish DN, Hosokawa PW, Linnebur SA, Metz KR, Nair KV, Saseen JJ, Vande Griend JP, Vu SP, Hirsch JD. Patient-level medication regimen complexity across populations with chronic disease. Clin Ther. 2013 Apr; 35(4):385-398.e1.
Score: 0.008
-
Valuck RJ, Williams SA, MacArthur M, Saseen JJ, Nair KV, McCollum M, Ensor JE. A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization. Clin Ther. 2003 Nov; 25(11):2936-57.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|